Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.

[1]  F. Valagussa,et al.  Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction , 2012, PharmacoEconomics.

[2]  J. Darbà,et al.  Economic Evaluation of Triflusal and Aspirin in the Treatment of Acute Myocardial Infarction , 2012, PharmacoEconomics.

[3]  Julie Taylor,et al.  Women's Health Research: Progress, Pitfalls, and Promise , 2011 .

[4]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.

[5]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[6]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.

[7]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[8]  E. Arias.  United States life tables by Hispanic origin. , 2010, Vital and health statistics. Series 2, Data evaluation and methods research.

[9]  Rod S Taylor,et al.  Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[10]  D. Mozaffarian,et al.  Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults A Scientific Statement From the American Heart Association Endorsed by the Preventive Cardiovascular Nurses Association and the Society of Behavioral Medicine , 2010 .

[11]  Sidney C. Smith,et al.  Racial and Ethnic Differences in the Treatment of Acute Myocardial Infarction: Findings From the Get With The Guidelines-Coronary Artery Disease Program , 2010, Circulation.

[12]  B. Egan,et al.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. , 2010, JAMA.

[13]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[14]  Eric Boerwinkle,et al.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. , 2010, Journal of the American College of Cardiology.

[15]  Jennifer G. Robinson,et al.  Evaluation of the American Heart Association Cardiovascular Disease Prevention Guideline for Women , 2010, Circulation. Cardiovascular quality and outcomes.

[16]  L. Newby,et al.  Twelve-Year Follow-Up of American Women's Awareness of Cardiovascular Disease Risk and Barriers to Heart Health , 2010, Circulation. Cardiovascular quality and outcomes.

[17]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[18]  Stephen D. Persell,et al.  Distribution of 10-Year and Lifetime Predicted Risks for Cardiovascular Disease in US Adults: Findings From the National Health and Nutrition Examination Survey 2003 to 2006 , 2010, Circulation. Cardiovascular quality and outcomes.

[19]  J. Donnelly,et al.  Group versus individual phone-based obesity treatment for rural women. , 2010, Eating behaviors.

[20]  F. Penedo,et al.  Resiliency in the face of disadvantage: do Hispanic cultural characteristics protect health outcomes? , 2009, Journal of personality.

[21]  C. Clar,et al.  The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. , 2009, Health technology assessment.

[22]  C. Cannon,et al.  Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality-Improvement Program , 2009, Circulation. Cardiovascular quality and outcomes.

[23]  Adrian G. Barnett,et al.  Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet , 2009, PloS one.

[24]  Lawrence J. Appel,et al.  State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. , 2009, Circulation.

[25]  E. Benjamin,et al.  AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention , 2009, Circulation.

[26]  J. Colquitt,et al.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. , 2009, Health technology assessment.

[27]  D. Lloyd‐Jones,et al.  Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile , 2009, Circulation.

[28]  R Mann,et al.  Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. , 2009, Health technology assessment.

[29]  P Barton,et al.  Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. , 2009, Health technology assessment.

[30]  J. Broderick,et al.  Temporal Trends in Public Awareness of Stroke: Warning Signs, Risk Factors, and Treatment , 2009, Stroke.

[31]  Michael J. Pencina,et al.  Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[32]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[33]  D. Levy,et al.  Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005 , 2009, Circulation.

[34]  R. Collins,et al.  Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels , 2009, Circulation. Cardiovascular quality and outcomes.

[35]  J. Shepherd,et al.  Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation. , 2006, Health technology assessment.

[36]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[37]  L. Pradelli,et al.  The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy , 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[38]  D. Lloyd‐Jones,et al.  Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. , 2008, Preventive medicine.

[39]  K. Lorig,et al.  The expert patients programme online, a 1-year study of an Internet-based self-management programme for people with long-term conditions , 2008, Chronic illness.

[40]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[41]  Mary Catherine Beach,et al.  Patient centeredness, cultural competence and healthcare quality. , 2008, Journal of the National Medical Association.

[42]  K. Grimmer-Somers,et al.  The effectiveness of clinical guideline implementation strategies--a synthesis of systematic review findings. , 2008, Journal of evaluation in clinical practice.

[43]  M. Roman,et al.  Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. , 2008, The American journal of medicine.

[44]  Anke J. E. de Veer,et al.  Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review , 2008, BMC Medical Informatics Decis. Mak..

[45]  M. Ekman,et al.  Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden , 2008, Journal of Human Hypertension.

[46]  M. Turakhia,et al.  Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events , 2008, BMC family practice.

[47]  David Goff,et al.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. , 2008, Hypertension.

[48]  L. Mosca.  Aspirin chemoprevention: one size does not fit all. , 2008, Circulation.

[49]  A. Algra,et al.  University of Groningen Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age , gender , and varying cardiovascular risk , 2017 .

[50]  T. Bodenheimer.  Coordinating care--a perilous journey through the health care system. , 2008, The New England journal of medicine.

[51]  B. Cheung,et al.  Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. , 2008, Annals of epidemiology.

[52]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[53]  L. Goldman,et al.  Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2008, Journal of General Internal Medicine.

[54]  Patricia Davidson,et al.  More Similarities Than Differences: An International Comparison of CVD Mortality and Risk Factors in Women , 2007, Health care for women international.

[55]  D. Flum,et al.  Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[56]  J. Kanis,et al.  The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden , 2008, Osteoporosis International.

[57]  David M Herrington,et al.  Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). , 2007, Archives of internal medicine.

[58]  Pierre Corvol,et al.  Self-measurement and self-titration in hypertension: a pilot telemedicine study. , 2007, American journal of hypertension.

[59]  Melonie P. Heron,et al.  Deaths: leading causes for 2004. , 2007, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[60]  V. Garovic,et al.  Hypertension in pregnancy: an emerging risk factor for cardiovascular disease , 2007, Nature Clinical Practice Nephrology.

[61]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[62]  M. Buxton,et al.  Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen , 2007, Heart.

[63]  M. Peek,et al.  Diabetes Health Disparities , 2007, Medical care research and review : MCRR.

[64]  J. Hippisley-Cox,et al.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study , 2007, BMJ : British Medical Journal.

[65]  Jiang He,et al.  Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. , 2007, Annals of epidemiology.

[66]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[67]  M. Postma,et al.  An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands. , 2007, Clinical therapeutics.

[68]  Rowena J Dolor,et al.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.

[69]  Hoangmai H Pham,et al.  Care patterns in Medicare and their implications for pay for performance. , 2007, The New England journal of medicine.

[70]  J. Barnhart,et al.  Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative. , 2007, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[71]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[72]  Michael Pignone,et al.  Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. , 2007, Archives of internal medicine.

[73]  Mark A. Hlatky,et al.  ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain , 2007 .

[74]  J. Matthews,et al.  The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking , 2007, Cost effectiveness and resource allocation : C/E.

[75]  Andrew D Oxman,et al.  Health Research Policy and Systems BioMed Central Review Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation , 2006 .

[76]  T. Edejer.  Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications , 2006, Health Research Policy and Systems.

[77]  Andrew D Oxman,et al.  Improving the use of research evidence in guideline development , 2007 .

[78]  M. Banerjee,et al.  Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk , 2006, Nature Clinical Practice Cardiovascular Medicine.

[79]  Laura Petersen,et al.  Does Pay-for-Performance Improve the Quality of Health Care? , 2006, Annals of Internal Medicine.

[80]  Judith Wylie-Rosett,et al.  Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee , 2006, Circulation.

[81]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[82]  S. Lydersen,et al.  Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[83]  B. Lindgren,et al.  The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. , 2006, Chest.

[84]  Ralph B D'Agostino,et al.  Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.

[85]  L. Mosca,et al.  National Study of Women’s Awareness, Preventive Action, and Barriers to Cardiovascular Health , 2006, Circulation.

[86]  Gianni Tognoni,et al.  Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.

[87]  I. Greer,et al.  Manifestations of chronic disease during pregnancy. , 2005, JAMA.

[88]  M. Schull,et al.  Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study , 2005, The Lancet.

[89]  A. Unger,et al.  Racial disparities in hypertension prevalence, awareness, and management. , 2005, Archives of internal medicine.

[90]  K. Markides,et al.  Aging, Migration, and Mortality: Current Status of Research on the Hispanic Paradox. , 2005, The journals of gerontology. Series B, Psychological sciences and social sciences.

[91]  P. Tillgren,et al.  A model for cost-effectiveness analyses of smoking cessation interventions applied to a Quit-and-Win contest for mothers of small children , 2005, Scandinavian journal of public health.

[92]  D. Flum,et al.  The costs of nonsurgical and surgical weight loss interventions: is an ounce of prevention really worth a pound of cure? , 2005, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[93]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[94]  Ralph D'Agostino,et al.  Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors , 2005, Annals of Internal Medicine.

[95]  L. Mosca,et al.  American Heart Association and American Stroke Association National Survey of Stroke Risk Awareness Among Women , 2005, Circulation.

[96]  Anne E Sales,et al.  Adherence to Heart-Healthy Behaviors in a Sample of the U.S. Population , 2005, Preventing chronic disease.

[97]  D. Levy,et al.  Novel Approach to Examining First Cardiovascular Events After Hypertension Onset , 2005, Hypertension.

[98]  D. Malone,et al.  Cost-effectiveness of sibutramine in the LOSE Weight Study: evaluating the role of pharmacologic weight-loss therapy within a weight management program. , 2005, Journal of managed care pharmacy : JMCP.

[99]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[100]  N. Sattar.  Do pregnancy complications and CVD share common antecedents? , 2004, Atherosclerosis. Supplements.

[101]  L. Mosca.  Summary of the American Heart Association’s Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[102]  M. Dimatteo.  Variations in Patients’ Adherence to Medical Recommendations: A Quantitative Review of 50 Years of Research , 2004, Medical care.

[103]  Constance K Haan,et al.  Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Circulation.

[104]  R. Jeffery,et al.  Mail and phone interventions for weight loss in a managed-care setting: Weigh-To-Be one-year outcomes , 2003, International Journal of Obesity.

[105]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[106]  R. H. Cox,et al.  A video lesson series is effective in changing the dietary intakes and food-related behaviors of low-income homemakers. , 2003, Journal of the American Dietetic Association.

[107]  Aniruddha M. Deshpande,et al.  Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.

[108]  R. Rosenheck,et al.  Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[109]  D. Southard,et al.  Clinical trial of an Internet-based case management system for secondary prevention of heart disease. , 2003, Journal of cardiopulmonary rehabilitation.

[110]  T. Fahey,et al.  The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis , 2003, Journal of hypertension.

[111]  M. Cabana,et al.  Physician adherence to preventive cardiology guidelines for women. , 2003, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[112]  J. Wheeler.  Can A Disease Self-Management Program Reduce Health Care Costs?: The Case of Older Women With Heart Disease , 2003, Medical care.

[113]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[114]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[115]  G. Prescott,et al.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.

[116]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[117]  F. Cluzeau,et al.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project , 2003 .

[118]  Benjamin Matthew Craig,et al.  Cost-effectiveness of gastric bypass for severe obesity. , 2002, The American journal of medicine.

[119]  J. Betancourt.  Cultural Competence in Health Care: Emerging Frameworks and Practical Approaches , 2002 .

[120]  J. Tu,et al.  Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes , 2002 .

[121]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[122]  J. Campinha-Bacote.  The Process of Cultural Competence in the Delivery of Healthcare Services: A Model of Care , 2002, Journal of transcultural nursing : official journal of the Transcultural Nursing Society.

[123]  Stephen Rollnick,et al.  Motivational Interviewing: Preparing People for Change, 2nd Edition , 2002 .

[124]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[125]  W. Miller,et al.  Motivational interviewing: preparing people for change. , 2002 .

[126]  B. Smedley,et al.  Unequal Treatment: Con-fronting Racial and Ethnic Disparities in Health Care , 2002 .

[127]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[128]  P. Lapuerta,et al.  Assessment of the association between blood pressure control and health care resource use. , 2001, Clinical therapeutics.

[129]  D. Nathan,et al.  Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial. , 2001, Journal of the American Dietetic Association.

[130]  M. Buxton,et al.  Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) , 2001, Journal of Human Hypertension.

[131]  A. Algra,et al.  Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery. , 2001, Journal of vascular surgery.

[132]  S. Phillips,et al.  Group office visits change dietary habits of patients with coronary artery disease-the dietary intervention and evaluation trial (D.I.E.T.). , 2001, The Journal of family practice.

[133]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[134]  Beverly Coleman-Miller,et al.  A Physician's Perspective on Minority Health , 2000, Health care financing review.

[135]  David R. Williams,et al.  Understanding and Addressing Racial Disparities in Health Care , 2000, Health care financing review.

[136]  M. Gornick.  Disparities in Medicare Services: Potential Causes, Plausible Explanations, and Recommendations , 2000, Health care financing review.

[137]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[138]  S. Oparil,et al.  Guide to Preventive Cardiology for Women , 1999 .

[139]  S. Oparil,et al.  AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. , 1999, Journal of the American College of Cardiology.

[140]  G. Kok,et al.  Effectiveness of health education and health promotion: meta-analyses of effect studies and determinants of effectiveness. , 1997, Patient education and counseling.

[141]  A. Bandura,et al.  Self-evaluative and self-efficacy mechanisms governing the motivational effects of goal systems. , 1983 .

[142]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .